nach oben

Erschienen in:

01.12.2012 | Original Article

HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantation

verfasst von: Qinlong Liu, Helge Bruns, Daniel Schultze, Yi Xue, Markus Zorn, Christa Flechtenmacher, Beate K. Straub, Ursula Rauen, Peter Schemmer

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Ischemia/reperfusion injury is an obstacle especially in steatotic livers, including those with steatosis induced by acute toxic stress. Recently, a modified histidine-tryptophan-ketoglutarate (HTK) solution, HTK-N, has been developed. This solution contains N-acetylhistidine, amino acids, and iron chelators. This study was designed to test the effects of HTK-N on preservation injury to rat livers after acute toxic injury.

Methods

Microvesicular steatosis was induced by a single dose of ethanol (8 g/kg BW). Livers were harvested and stored at 4 °C for 8 h with HTK or HTK-N before transplantation. Tissue and blood samples were taken at 1, 8, and 24 h after reperfusion to compare serum liver enzymes (aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase), standard histology, and immunohistochemistry for myeloperoxidase (MPO), caspase-3, and inducible nitric oxide synthase. Survival was compared after 1 week. For statistics, Analysis of Variance and t test were used.

Results

HTK-N improved survival from 12.5 % in HTK to 87.5 % (p < 0.05). Furthermore, liver enzymes were decreased to 2–75 % of HTK values (p < 0.05). Necrosis and leukocyte infiltration and MPO, caspase-3, and iNOS expression after transplantation were decreased (p < 0.05).

Conclusions

This study demonstrates that HTK-N protects liver grafts with microvesicular steatosis caused by acute toxic injury from cold ischemic injury better than standard HTK most likely via inhibition of hypoxic injury and oxidative stress and amelioration of the inflammatory reaction occurring upon reperfusion.

Schemmer P, Nickkholgh A, Gerling T, Weitz J, Büchler MW, Schmidt J (2009) Rescue allocation for liver transplantation within Eurotransplant: the Heidelberg experience. Clin Transplant 23(Suppl 21):42–48. doi:10.1111/j.1399-0012.2009.01109.x PubMedCrossRef

Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, Chayama K, Saibara T (2012) Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 47(5):586–595. doi:10.1007/s00535-012-0533-z PubMedCrossRef

Sirivatanauksorn Y, Taweerutchana V, Limsrichamrern S, Kositamongkol P, Mahawithitwong P, Asavakarn S, Tovikkai C, Sanphasitvong V (2012) Analysis of donor risk factors associated with graft outcomes in orthotopic liver transplantation. Transplant Proc 44(2):320–323. doi:10.1016/j.transproceed.2011.12.031 PubMedCrossRef

Pokorny H, Gruenberger T, Soliman T, Rockenschaub S, Langle F, Steininger R (2000) Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantation. Transpl Int: Off J of the Eur Soc for Organ Transplant 13(Suppl 1):S154–S157

Ke B, Lipshutz GS, Kupiec-Weglinski JW (2006) Gene therapy in liver ischemia and reperfusion injury. Curr Pharm Des 12(23):2969–2975PubMedCrossRef

Cieslak B, Lewandowski Z, Urban M, Ziarkiewicz-Wroblewska B, Krawczyk M (2009) Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters. Transplant Proc 41(8):2985–2988. doi:10.1016/j.transproceed.2009.08.019 PubMedCrossRef

Stegemann J, Hirner A, Rauen U, Minor T (2010) Use of a new modified HTK solution for machine preservation of marginal liver grafts. J Surg Res 160(1):155–162. doi:10.1016/j.jss.2008.10.021 PubMedCrossRef

Wu K, Turk TR, Rauen U, Su S, Feldkamp T, de Groot H, Wiswedel I, Baba HA, Kribben A, Witzke O (2011) Prolonged cold storage using a new histidine-tryptophan-ketoglutarate-based preservation solution in isogeneic cardiac mouse grafts. Eur Hear J 32(4):509–516. doi:10.1093/eurheartj/ehq135 CrossRef

Kerkweg U, Li T, de Groot H, Rauen U (2002) Cold-induced apoptosis of rat liver cells in University of Wisconsin solution: the central role of chelatable iron. Hepatology 35(3):560–567. doi:10.1053/jhep.2002.31869 PubMedCrossRef

10.

Rauen U, Kerkweg U, de Groot H (2007) Iron-dependent vs. iron-independent cold-induced injury to cultured rat hepatocytes: a comparative study in physiological media and organ preservation solutions. Cryobiology 54(1):77–86. doi:10.1016/j.cryobiol.2006.11.008 PubMedCrossRef

11.

Rauen U, Petrat F, Li T, De Groot H (2000) Hypothermia injury/cold-induced apoptosis—evidence of an increase in chelatable iron causing oxidative injury in spite of low O₂₋/H₂O₂ formation. FASEB J: Off Publ of the Fed of Am Soc for Exp Biol 14(13):1953–1964. doi:10.1096/fj.00-0071com

12.

Rauen U, Polzar B, Stephan H, Mannherz HG, de Groot H (1999) Cold-induced apoptosis in cultured hepatocytes and liver endothelial cells: mediation by reactive oxygen species. FASEB J: Off Publ of the Fed of Am Soc for Exp Biol 13(1):155–168

13.

Rauen U, de Groot H (2008) Inherent toxicity of organ preservation solutions to cultured hepatocytes. Cryobiology 56(1):88–92. doi:10.1016/j.cryobiol.2007.09.003 PubMedCrossRef

14.

Rauen U, Klempt S, de Groot H (2007) Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators. Cell Mol Life Sci: CMLS 64(2):192–205. doi:10.1007/s00018-006-6456-1 PubMedCrossRef

15.

Dalal P, Romani A (2010) Adenosine triphosphate depletion by cyanide results in a Na(+)-dependent Mg(2+) extrusion from liver cells. Metab Clin Exp 59(11):1663–1671. doi:10.1016/j.metabol.2010.03.019 PubMedCrossRef

16.

Frank A, Rauen U, de Groot H (2000) Protection by glycine against hypoxic injury of rat hepatocytes: inhibition of ion fluxes through nonspecific leaks. J Hepatol 32(1):58–66PubMedCrossRef

17.

Fuckert O, Rauen U, De Groot H (2000) A role for sodium in hypoxic but not in hypothermic injury to hepatocytes and LLC-PK1 cells. Transplantation 70(5):723–730PubMedCrossRef

18.

Weinberg JM, Venkatachalam MA, Roeser NF, Nissim I (2000) Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc Natl Acad Sci U S A 97(6):2826–2831PubMedCrossRef

19.

Uhlmann D, Uhlmann S, Spiegel HU (2000) Endothelin/nitric oxide balance influences hepatic ischemia-reperfusion injury. J Cardiovasc Pharmacol 36(5 Suppl 1):S212–S214PubMed

20.

Wu B, Iwakiri R, Tsunada S, Utsumi H, Kojima M, Fujise T, Ootani A, Fujimoto K (2002) iNOS enhances rat intestinal apoptosis after ischemia-reperfusion. Free Radic Biol Med 33(5):649–658PubMedCrossRef

21.

Yagnik GP, Takahashi Y, Tsoulfas G, Reid K, Murase N, Geller DA (2002) Blockade of the l-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 36(3):573–581. doi:10.1053/jhep.2002.35058 PubMedCrossRef

22.

Stegemann J, Hirner A, Rauen U, Minor T (2009) Gaseous oxygen persufflation or oxygenated machine perfusion with Custodiol-N for long-term preservation of ischemic rat livers? Cryobiology 58(1):45–51. doi:10.1016/j.cryobiol.2008.10.127 PubMedCrossRef

23.

Liu Q, Bruns H, Nickkholgh A, Schemmer P (2009) Custodiol-N attenuates reperfusion injury of steatotic rat livers. In: Abstracts of the 5th ELITA-ELTR (European Society for Organ Transplantation-European Liver and Intestine Transplant Association) Winter Meeting, Are, Sweden, 19–21 March 2009. Transplant International: Official Journal of the European Society for Organ Transplantation 22 Suppl 1:1–7. doi:10.1111/j.1432-2277.2009.00853.x

24.

Enomoto N, Yamashina S, Kono H, Schemmer P, Rivera CA, Enomoto A, Nishiura T, Nishimura T, Brenner DA, Thurman RG (1999) Development of a new, simple rat model of early alcohol-induced liver injury based on sensitization of Kupffer cells. Hepatology 29(6):1680–1689. doi:10.1002/hep.510290633 PubMedCrossRef

25.

Gao W, Lemasters JJ, Thurman RG (1993) Development of a new method for hepatic rearterialization in rat orthotopic liver transplantation. Reduction of liver injury and improvement of surgical outcome by arterialization. Transplantation 56(1):19–24PubMedCrossRef

26.

Schemmer P, Schoonhoven R, Swenberg JA, Bunzendahl H, Thurman RG (1998) Gentle in situ liver manipulation during organ harvest decreases survival after rat liver transplantation: role of Kupffer cells. Transplantation 65(8):1015–1020PubMedCrossRef

27.

Bergmeyer H (1988) Methods of enzymatic analysis. Academic Press, New York

28.

Nickkholgh A, Weitz J, Encke J, Sauer P, Mehrabi A, Büchler MW, Schmidt J, Schemmer P (2007) Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature. Nephrol Dial Transplant: Off Publ of the Eur Dial and Transplant Assoc-Eur Ren Assoc 22(Suppl 8):viii29–viii36. doi:10.1093/ndt/gfm654

29.

Schemmer P, Nickkholgh A, Hinz U, Gerling T, Mehrabi A, Sauer P, Encke J, Friess H, Weitz J, Büchler MW, Schmidt J (2007) Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis. Transplant Proc 39(2):529–534. doi:10.1016/j.transproceed.2006.12.002 PubMedCrossRef

30.

Rauen U, de Groot H (2004) New insights into the cellular and molecular mechanisms of cold storage injury. J of Invest Med: The Off Publ of the Am Fed for Clin Res 52(5):299–309

31.

Hui AM, Kawasaki S, Makuuchi M, Nakayama J, Ikegami T, Miyagawa S (1994) Liver injury following normothermic ischemia in steatotic rat liver. Hepatology 20(5):1287–1293PubMedCrossRef

32.

Zimmerman BJ, Grisham MB, Granger DN (1990) Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 258(2 Pt 1):G185–G190PubMed

33.

Bruns H, Watanpour I, Gebhard MM, Flechtenmacher C, Galli U, Schulze-Bergkamen H, Zorn M, Büchler MW, Schemmer P (2011) Glycine and taurine equally prevent fatty livers from Kupffer cell-dependent injury: an in vivo microscopy study. Microcirculation 18(3):205–213. doi:10.1111/j.1549-8719.2010.00078.x PubMedCrossRef

34.

Schemmer P, Enomoto N, Bradford BU, Bunzendahl H, Raleigh JA, Lemasters JJ, Thurman RG (2001) Activated Kupffer cells cause a hypermetabolic state after gentle in situ manipulation of liver in rats. Am J Physiol Gastrointest Liver Physiol 280(6):G1076–G1082PubMed

35.

Wheeler MD, Ikejema K, Enomoto N, Stacklewitz RF, Seabra V, Zhong Z, Yin M, Schemmer P, Rose ML, Rusyn I, Bradford B, Thurman RG (1999) Glycine: a new anti-inflammatory immunonutrient. Cell Mol Life Sci: CMLS 56(9–10):843–856PubMedCrossRef

36.

Szabo G, Bala S (2010) Alcoholic liver disease and the gut-liver axis. World J Gastroenterol: WJG 16(11):1321–1329PubMedCrossRef

37.

Enomoto N, Ikejima K, Bradford B, Rivera C, Kono H, Brenner DA, Thurman RG (1998) Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 115(2):443–451PubMedCrossRef

38.

DeCarli LM, Lieber CS (1967) Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet. J Nutr 91(3):331–336PubMed

39.

Lieber CS, Jones DP, Decarli LM (1965) Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Investig 44:1009–1021. doi:10.1172/JCI105200 PubMedCrossRef

40.

Lieber CS, Spritz N, DeCarli LM (1969) Fatty liver produced by dietary deficiencies: its pathogenesis and potentiation by ethanol. J of Lipid Res 10(3):283–287

41.

Devlin J, Dunne JB, Sherwood RA, Chambers SM, Tan KC, Peters TJ, Williams R (1995) Relationship between early liver graft viability and enzyme activities in effluent preservation solution. Transplantation 60(7):627–631PubMedCrossRef

42.

Carini R, Bellomo G, Grazia De Cesaris M, Albano E (1997) Glycine protects against hepatocyte killing by KCN or hypoxia by preventing intracellular Na⁺ overload in the rat. Hepatology 26(1):107–112. doi:10.1002/hep.510260114 PubMedCrossRef

43.

Arkadopoulos N, Nastos C, Kalimeris K, Economou E, Theodoraki K, Kouskouni E, Pafiti A, Kostopanagiotou G, Smyrniotis V (2010) Iron chelation for amelioration of liver ischemia-reperfusion injury. Hemoglobin 34(3):265–277. doi:10.3109/03630269.2010.484766 PubMedCrossRef

44.

Hoffmann K, Büchler MW, Schemmer P (2011) Supplementation of amino acids to prevent reperfusion injury after liver surgery and transplantation—where do we stand today? Clin Nutr 30(2):143–147. doi:10.1016/j.clnu.2010.09.006 PubMedCrossRef

45.

Schemmer P, Schoonhoven R, Swenberg JA, Bunzendahl H, Raleigh JA, Lemasters JJ, Thurman RG (1999) Gentle organ manipulation during harvest as a key determinant of survival of fatty livers after transplantation in the rat. Transplant Int: Off J of the Eur Soc for Organ Transplant 12(5):351–359CrossRef

46.

Enomoto N, Ikejima K, Yamashina S, Enomoto A, Nishiura T, Nishimura T, Brenner DA, Schemmer P, Bradford BU, Rivera CA, Zhong Z, Thurman RG (2000) Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver. Am J Physiol Gastrointest Liver Physiol 279(1):G100–G106PubMed

47.

Yadav SS, Howell DN, Gao W, Steeber DA, Harland RC, Clavien PA (1998) l-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol 275(6 Pt 1):G1341–G1352PubMed

48.

Andrades M, Ritter C, de Oliveira MR, Streck EL, Fonseca Moreira JC, Dal-Pizzol F (2011) Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress. J Surg Res 167(2):e307–e313. doi:10.1016/j.jss.2009.08.005 PubMedCrossRef

49.

Burch JB, Svendsen E, Siegel PD, Wagner SE, von Essen S, Keefe T, Mehaffy J, Martinez AS, Bradford M, Baker L, Cranmer B, Saito R, Tessari J, Linda P, Andersen C, Christensen O, Koehncke N, Reynolds SJ (2010) Endotoxin exposure and inflammation markers among agricultural workers in Colorado and Nebraska. J Toxic Environ Health A 73(1):5–22. doi:10.1080/15287390903248604 CrossRef

50.

Yoshida M, Sasaki M, Nakabayashi I, Akashi M, Tomiyasu T, Yoshikawa N, Kojima T, Ohno N, Yamada M (2009) Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis. Clin Exp Rheumatol 27(1 Suppl 52):S28–S32PubMed

51.

Palmes D, Minin E, Budny T, Uhlmann D, Armann B, Stratmann U, Herbst H, Spiegel HU (2005) The endothelin/nitric oxide balance determines small-for-size liver injury after reduced-size rat liver transplantation. Virchows Arch: an Int J of Pathol 447(4):731–741. doi:10.1007/s00428-005-0006-3 CrossRef

52.

Uhlmann D, Armann B, Gaebel G, Ludwig S, Hess J, Pietsch UC, Escher E, Fiedler M, Tannapfel A, Hauss J, Witzigmann H (2003) Endothelin A receptor blockade reduces hepatic ischemia/reperfusion injury after warm ischemia in a pig model. J of Gastrointest Surg: Off J of the Soc for Surg of the Aliment Tract 7(3):331–339

53.

Bahde R, Palmes D, Gemsa O, Minin E, Stratmann U, de Groot H, Rauen U, Spiegel HU (2008) Attenuated cold storage injury of rat livers using a modified HTK solution. J Surg Res 146(1):49–56. doi:10.1016/j.jss.2007.08.011 PubMedCrossRef

54.

Carini R, Bellomo G, Benedetti A, Fulceri R, Gamberucci A, Parola M, Dianzani MU, Albano E (1995) Alteration of Na⁺ homeostasis as a critical step in the development of irreversible hepatocyte injury after adenosine triphosphate depletion. Hepatology 21(4):1089–1098PubMed

55.

Carini R, De Cesaris MG, Splendore R, Bagnati M, Albano E (2000) Ischemic preconditioning reduces Na(+) accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia. Hepatology 31(1):166–172. doi:10.1002/hep.510310125 PubMedCrossRef

56.

Schemmer P, Golling M, Kraus T, Mayatepek E, Herfarth C, Klar E (2001) Glycine reduces reperfusion injury in human liver transplantation: our first patients. Transplant Proc 33(7–8):3750–3752PubMedCrossRef

57.

Atahan E, Ergun Y, Kurutas EB, Alici T (2010) Protective effect of zinc aspartate on long-term ischemia-reperfusion injury in rat skeletal muscle. Biol Trace Elem Res 137(2):206–215. doi:10.1007/s12011-009-8568-6 PubMedCrossRef

58.

Natori S, Selzner M, Valentino KL, Fritz LC, Srinivasan A, Clavien PA, Gores GJ (1999) Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 68(1):89–96PubMedCrossRef

59.

Rentsch M, Beham A, Iesalnieks I, Mirwald T, Anthuber M, Jauch KW (2001) Impact of prolonged cold ischemia and reperfusion on apoptosis, activation of caspase 3, and expression of bax after liver transplantation in the rat. Transplant Proc 33(1–2):850–851PubMedCrossRef

60.

Zhang Y, Dong Y, Wu X, Lu Y, Xu Z, Knapp A, Yue Y, Xu T, Xie Z (2010) The mitochondrial pathway of anesthetic isoflurane-induced apoptosis. J Biol Chem 285(6):4025–4037. doi:10.1074/jbc.M109.065664 PubMedCrossRef

61.

Abu-Amara M, Yang SY, Seifalian A, Davidson B, Fuller B (2012) The nitric oxide pathway—evidence and mechanisms for protection against liver ischaemia reperfusion injury. Liver Int: Off J of the Int Assoc for the Study of the Liver 32(4):531–543. doi:10.1111/j.1478-3231.2012.02755.x CrossRef

62.

Koeppel TA, Mihaljevic N, Kraenzlin B, Loehr M, Jesenofsky R, Post S, Palma P (2007) Enhanced iNOS gene expression in the steatotic rat liver after normothermic ischemia. Eur Sur Res Europaische Chirurgische Forsch Rech Chirurgicales Europeennes 39(5):303–311. doi:10.1159/000104401 CrossRef

63.

Kaizu T, Ikeda A, Nakao A, Takahashi Y, Tsung A, Kohmoto J, Toyokawa H, Shao L, Bucher BT, Tomiyama K, Nalesnik MA, Murase N, Geller DA (2006) Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival. Hepatology 43(3):464–473. doi:10.1002/hep.21067 PubMedCrossRef

Titel: HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantation
verfasst von: Qinlong Liu
Helge Bruns
Daniel Schultze
Yi Xue
Markus Zorn
Christa Flechtenmacher
Beate K. Straub
Ursula Rauen
Peter Schemmer
Publikationsdatum: 01.12.2012
Verlag: Springer-Verlag
Erschienen in: Langenbeck's Archives of Surgery / Ausgabe 8/2012
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-012-1022-9

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2012

Management of the difficult duodenal stump in penetrating duodenal ulcer disease: a comparative analysis of duodenojejunostomy with “classical” stump closure (Nissen–Bsteh)

Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy

Chronic pain after open inguinal hernia surgery: suture fixation versus self-adhesive mesh repair

Risk of wound hematoma at carotid endarterectomy under dual antiplatelet therapy

A randomised, multi-centre, prospective, observer and patient blind study to evaluate a non-absorbable polypropylene mesh vs. a partly absorbable mesh in incisional hernia repair

Central hepatectomy under sequential hemihepatic control

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“